Mettler-Toledo International, Inc. $MTD Shares Bought by CW Advisors LLC

Key Points

• CW Advisors LLC increased its stake in Mettler-Toledo by 250.3% during the first quarter, owning 620 shares valued at approximately $737,000.
• Insiders have recently sold a significant number of shares, with Director Thomas P. Salice selling 1,062 shares for over $1.38 million, representing a 78.96% decrease in his position.
• Wall Street analysts have set a consensus price target of $1,311.11 for Mettler-Toledo, with Citigroup raising its price target from $1,400.00 to $1,600.00 and issuing a "buy" rating.

CW Advisors LLC boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 250.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 620 shares of the medical instruments supplier's stock after buying an additional 443 shares during the period. CW Advisors LLC's holdings in Mettler-Toledo International were worth $737,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Zions Bancorporation National Association UT acquired a new position in shares of Mettler-Toledo International in the 1st quarter valued at $43,000. Golden State Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares during the last quarter. Menard Financial Group LLC acquired a new position in shares of Mettler-Toledo International in the 4th quarter valued at $67,000. Blue Trust Inc. lifted its stake in shares of Mettler-Toledo International by 520.0% in the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after purchasing an additional 52 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after purchasing an additional 25 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. The trade was a 5.56% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on MTD. Citigroup upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price objective for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Bank of America boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price objective for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Barclays initiated coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective on the stock. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,286.41 on Wednesday. The stock's 50-day moving average is $1,232.48 and its two-hundred day moving average is $1,186.72. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01. The company has a market cap of $26.50 billion, a price-to-earnings ratio of 32.58, a price-to-earnings-growth ratio of 3.87 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the business posted $9.65 EPS. The business's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.